相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Activity of therapeutic JAK 1/2 blockade in graft-versus-host disease
Silvia Spoerl et al.
BLOOD (2014)
Selective JAK2 Inhibition Specifically Decreases Hodgkin Lymphoma and Mediastinal Large B-cell Lymphoma Growth In Vitro and In Vivo
Yansheng Hao et al.
CLINICAL CANCER RESEARCH (2014)
Myeloid-derived suppressor cells in breast cancer
Joseph Markowitz et al.
BREAST CANCER RESEARCH AND TREATMENT (2013)
The Role of JAK Pathway Dysregulation in the Pathogenesis and Treatment of Acute Myeloid Leukemia
Hun Ju Lee et al.
CLINICAL CANCER RESEARCH (2013)
AZD1480: A Phase I Study of a Novel JAK2 Inhibitor in Solid Tumors
Elizabeth R. Plimack et al.
ONCOLOGIST (2013)
Comprehensive review of JAK inhibitors in myeloproliferative neoplasms
Mohamad Bassam Sonbol et al.
THERAPEUTIC ADVANCES IN HEMATOLOGY (2013)
IFNγR signaling mediates alloreactive T-cell trafficking and GVHD
Jaebok Choi et al.
BLOOD (2012)
Sequencing a mouse acute promyelocytic leukemia genome reveals genetic events relevant for disease progression
Lukas D. Wartman et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
The JAK inhibitor AZD1480 regulates proliferation and immunity in Hodgkin lymphoma
E. Derenzini et al.
BLOOD CANCER JOURNAL (2011)
NCI First International Workshop on The Biology, Prevention, and Treatment of Relapse After Allogeneic Hematopoietic Stem Cell Transplantation: Report from the Committee on the Biology Underlying Recurrence of Malignant Disease following Allogeneic HSCT: Graft-versus-Tumor/Leukemia Reaction
Jeffrey S. Miller et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2010)
Constitutively active Stat5b in CD4+ T cells inhibits graft-versus-host disease lethality associated with increased regulatory T-cell potency and decreased T effector cell responses
Christine Vogtenhuber et al.
BLOOD (2010)
In vivo administration of hypomethylating agents mitigate graft-versus-host disease without sacrificing graft-versus-leukemia
Jaebok Choi et al.
BLOOD (2010)
CYT387, a novel JAK2 inhibitor, induces hematologic responses and normalizes inflammatory cytokines in murine myeloproliferative neoplasms
Jeffrey W. Tyner et al.
BLOOD (2010)
Preclinical characterization of the selective JAK1/2 inhibitor INCB018424: therapeutic implications for the treatment of myeloproliferative neoplasms
Alfonso Quintas-Cardama et al.
BLOOD (2010)
Bone marrow myeloid-derived suppressor cells (MDSCs) inhibit graft-versus-host disease (GVHD) via an arginase-1-dependent mechanism that is up-regulated by interleukin-13
Steven L. Highfill et al.
BLOOD (2010)
New perspectives on the biology of acute GVHD
S. Paczesny et al.
BONE MARROW TRANSPLANTATION (2010)
Recent patents in the discovery of small molecule inhibitors of JAK3
Lawrence J. Wilson
EXPERT OPINION ON THERAPEUTIC PATENTS (2010)
Reciprocal differentiation and tissue-specific pathogenesis of Th1, Th2, and Th17 cells in graft-versus-host disease
Tangsheng Yi et al.
BLOOD (2009)
The JAK2 Inhibitor AZD1480 Potently Blocks Stat3 Signaling and Oncogenesis in Solid Tumors
Michael Hedvat et al.
CANCER CELL (2009)
Efficacy of TG101348, a selective JAK2 inhibitor, in treatment of a murine model of JAK2V617F-induced polycythemia vera
Gerlinde Werning et al.
CANCER CELL (2008)
Real-time imaging of ligand-induced IKK activation in intact cells and in living mice
S Gross et al.
NATURE METHODS (2005)
The JAK/STAT signaling pathway
JS Rawlings et al.
JOURNAL OF CELL SCIENCE (2004)
Interferon-γ:: an overview of signals, mechanisms and functions
K Schroder et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2004)
Kinetics of in vivo elimination of suicide gene-expressing T cells affects engraftment, graft-versus-host disease, and graft-versus-leukemia after allogeneic bone marrow transplantation
MP Rettig et al.
JOURNAL OF IMMUNOLOGY (2004)
High-penetrance mouse model of acute promyelocytic leukemia with very low levels of PML-RARα expression
P Westervelt et al.
BLOOD (2003)
Blockade of programmed death-1 engagement accelerates graft-versus-host disease lethality by an IFN-γ-dependent mechanism
BR Blazar et al.
JOURNAL OF IMMUNOLOGY (2003)
分享论文
